Marketbeat

Published October 10, 2026

Cybin Inc. (NASDAQ: HELP) Stock Has Average Target Price of $46.33 - MarketBeat

Read the full story at Marketbeat

Cybin remains a high-risk clinical-stage biotech : The company develops psychedelic ... Cybin Inc is a clinical-stage biotechnology company focused on.